As of 2026-02-04, 新型CGRP受体拮抗剂 (Gepants)'s data on the DeepSeek platform in the 偏头痛急性治疗药物 category shows: The overall mention rate is 0.00%, below the industry average by 8.9 percentage points, with significant room for improvement. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
新型CGRP受体拮抗剂 (Gepants)'s Mention Rate is 0.00%, lower than 0.6% of competitors
新型CGRP受体拮抗剂 (Gepants)'s First Mention is 0.00%, lower than 0.9% of competitors
新型CGRP受体拮抗剂 (Gepants)'s Preferred Rate is 0.00%, lower than 100.0% of competitors
新型CGRP受体拮抗剂 (Gepants)'s Positive Rate is 0.00%, lower than 8.9% of competitors
新型CGRP受体拮抗剂 (Gepants)'s Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| 新新型CGRP受体拮抗剂 (Gepants) (Current Brand) | 0% | 0% | 0% | 0% | 0% | View Details |
